J&J's Spinoff Kenvue Valued at $40 Billion. What's Ahead for Consumer Health.
Kenvue, Johnson & Johnson's consumer health business, could IPO as soon as this week.
Source: barrons.com
Stay updated with breaking news from Ulvr Ln. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Kenvue, Johnson & Johnson's consumer health business, could IPO as soon as this week.
The deal is the biggest cash takeover of the pandemic